| Patients . | Age (years) . | Preop TPR (Dynes.s.cm−5) . | ECLS mode . | Indication for ECLS . | Duration of ECLS (days) . | Extubation on ECLS . | Complications . | Outcome . | PH therapy . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | 1285 | Peripheral VA | RV failure, Pulmonary oedema | 39 | No | Renal failure, sepsis | death | - |
| 2 | 52 | 929 | VV (dual lumen) | Severe hypoxaemia | 5 | Yes | SVT | Alive 27 months | No |
| 3 | 57 | 1508 | Central VA, then VV (dual lumen) | RV failure, hypoxaemia | 5 (VA), 11 (VV) | No | Chest bleeding, subdural haematoma, VFib | Alive 12 months | Yes |
| 4 | 53 | 1675 | Central VA | Haemorrhagic pulmonary oedema | 3 | No | Delirium, pneumonia | Alive 11 months | No |
| 5 | 53 | 800 | VV (dual lumen) | Pneumonia | 6 | No | SVT | Alive 9 months | No |
| 6 | 45 | 2667 | Central VA | RV failure | 3 | No | Pneumonia | Alive 6 months | Yes |
| Patients . | Age (years) . | Preop TPR (Dynes.s.cm−5) . | ECLS mode . | Indication for ECLS . | Duration of ECLS (days) . | Extubation on ECLS . | Complications . | Outcome . | PH therapy . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | 1285 | Peripheral VA | RV failure, Pulmonary oedema | 39 | No | Renal failure, sepsis | death | - |
| 2 | 52 | 929 | VV (dual lumen) | Severe hypoxaemia | 5 | Yes | SVT | Alive 27 months | No |
| 3 | 57 | 1508 | Central VA, then VV (dual lumen) | RV failure, hypoxaemia | 5 (VA), 11 (VV) | No | Chest bleeding, subdural haematoma, VFib | Alive 12 months | Yes |
| 4 | 53 | 1675 | Central VA | Haemorrhagic pulmonary oedema | 3 | No | Delirium, pneumonia | Alive 11 months | No |
| 5 | 53 | 800 | VV (dual lumen) | Pneumonia | 6 | No | SVT | Alive 9 months | No |
| 6 | 45 | 2667 | Central VA | RV failure | 3 | No | Pneumonia | Alive 6 months | Yes |
ECLS: extracorporeal life support; VA: veno-arterial; VV: veno-venous; MV: mechanical ventilation; VFib: ventricular fibrillation; SVT: supraventricular tachycardia; RV failure: right ventricular failure.
| Patients . | Age (years) . | Preop TPR (Dynes.s.cm−5) . | ECLS mode . | Indication for ECLS . | Duration of ECLS (days) . | Extubation on ECLS . | Complications . | Outcome . | PH therapy . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | 1285 | Peripheral VA | RV failure, Pulmonary oedema | 39 | No | Renal failure, sepsis | death | - |
| 2 | 52 | 929 | VV (dual lumen) | Severe hypoxaemia | 5 | Yes | SVT | Alive 27 months | No |
| 3 | 57 | 1508 | Central VA, then VV (dual lumen) | RV failure, hypoxaemia | 5 (VA), 11 (VV) | No | Chest bleeding, subdural haematoma, VFib | Alive 12 months | Yes |
| 4 | 53 | 1675 | Central VA | Haemorrhagic pulmonary oedema | 3 | No | Delirium, pneumonia | Alive 11 months | No |
| 5 | 53 | 800 | VV (dual lumen) | Pneumonia | 6 | No | SVT | Alive 9 months | No |
| 6 | 45 | 2667 | Central VA | RV failure | 3 | No | Pneumonia | Alive 6 months | Yes |
| Patients . | Age (years) . | Preop TPR (Dynes.s.cm−5) . | ECLS mode . | Indication for ECLS . | Duration of ECLS (days) . | Extubation on ECLS . | Complications . | Outcome . | PH therapy . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 64 | 1285 | Peripheral VA | RV failure, Pulmonary oedema | 39 | No | Renal failure, sepsis | death | - |
| 2 | 52 | 929 | VV (dual lumen) | Severe hypoxaemia | 5 | Yes | SVT | Alive 27 months | No |
| 3 | 57 | 1508 | Central VA, then VV (dual lumen) | RV failure, hypoxaemia | 5 (VA), 11 (VV) | No | Chest bleeding, subdural haematoma, VFib | Alive 12 months | Yes |
| 4 | 53 | 1675 | Central VA | Haemorrhagic pulmonary oedema | 3 | No | Delirium, pneumonia | Alive 11 months | No |
| 5 | 53 | 800 | VV (dual lumen) | Pneumonia | 6 | No | SVT | Alive 9 months | No |
| 6 | 45 | 2667 | Central VA | RV failure | 3 | No | Pneumonia | Alive 6 months | Yes |
ECLS: extracorporeal life support; VA: veno-arterial; VV: veno-venous; MV: mechanical ventilation; VFib: ventricular fibrillation; SVT: supraventricular tachycardia; RV failure: right ventricular failure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
